background: While intrauterine insemination (IUI), a simple, inexpensive and non-invasive technique, is the most used assisted reproduction technology (ART) worldwide, the risk of major birth defects following IUI is paradoxically not well documented. results: Compared with naturally conceived singletons, singletons born after IUI and IVFT had a higher prevalence of major congenital malformations, with adjusted odd ratios (AOR) of 2.0 [95% confidence interval (CI) 1.0 -3.8] and 2.0 (CI 1.3-3.1); 3.6 and 4.2% of infants born, respectively. All twins and unlike-sex twins born after IVFT but not IUI, have an increased prevalence of major birth defects compared with naturally conceived twins; AOR of 3.0 (CI 1.6 -5.6) and 3.7 (CI 1.1 -16.9), respectively. When comparing IUI with IVFT, no differences were observed for singletons (AOR 1.0; CI 0.4-2.2), all twins (AOR 0.4; CI 0.1 -1.2) and unlike-sex twins (AOR 0.3; CI 0.1-4.5).
Introduction
Intrauterine insemination (IUI) is commonly offered to couples with subfertility and is used worldwide because it is simple, inexpensive and less invasive compared with IVF technologies [in vitro fertilization technologies (IVFT), including IVF, ICSI and frozen embryo transfer (FET)].
It is well established that children conceived following IVFT are at higher risk of major congenital abnormalities than children conceived in the general population (Rimm et al., 2004; Hansen et al., 2005; Reefhius et al., 2009) with no difference in the risk of birth defects between infants born after IVF and ICSI (Bonduelle et al., 2002; Hansen et al., 2002; Lie et al., 2005; Olson et al., 2005; Sutcliffe and Ludwig, 2007; Wennerholm et al., 2009) .
To date, only four studies with contradictory results have been interested in the possible risks of birth defects in children conceived with IUI (Klemetti et al., 2005; Olson et al., 2005; Zhu et al., 2006; El-Chaar et al., 2009) . In one study, more birth defects among singletons born of infertile couples treated with IUI were noted although this difference was not statistically significant (Olson et al., 2005) . Another study, carried out on either children born after IVFT or ovulation induction (OI) (with or without insemination) was unable to fully assess the risk of birth defects linked to insemination (Klemetti et al., 2005) . A third study found a significant increased risk of birth defects in infants born after IUI but did not separate singletons from multiples (El-Chaar et al., 2009) . Hence, the limitations of these studies include suboptimal sample size (Olson et al., 2005) and lack of appropriate comparison groups (Klemetti et al., 2005: OI and IUI pooled; El-Chaar et al., 2009 : one group considered OI, IUI, IVF and ICSI and no discrimination between twins and singletons). Finally, only one study with a large sample size and appropriate comparison groups (distinction between IUI, OI, IVF, ICSI and discrimination between singletons and twins) demonstrated the possible increase of congenital abnormalities in singletons conceived with IUI compared with singletons in the general population (Zhu et al., 2006) . For the diagnoses of congenital malformations, Zhu et al. (2006) used the International Classification of Disease, 10th revision ICD-10 (Q00 -Q99) from which they excluded only two minor congenital anomalies (Q17.0: accessory auricle, Q82.5: pigmented nevus) and three malformations with possible uncertain diagnoses (Q25.0: patent ductus arteriosus, Q53: undescended testis, Q65.0 -6: hip dislocation) while the European Surveillance of congenital anomalies, EUROCAT, excludes 150 minor anomalies, including the Q17.0, Q82.5, Q25.0, Q53, Q65.3, Q65.4, Q65.5 and Q65.6, excluded by study of Zhu et al. (2006) .
Because of the paucity of studies concerning the outcomes of IUI pregnancies compared with the plethora of data following IVF, we tend to ignore if children conceived with IUI are at higher risk for major birth defects than infants conceived naturally and if this risk is similar to or different from the risk observed in children born after IVFT.
Thanks to the Burgundy perinatal network (BPN) and data from the assisted reproduction technology (ART: IVFT and IUI) centres of Burgundy, we compared the prevalence of major congenital malformations (according to the standardized classification scheme of EUROCAT; Chapters 3.2 and 3.3) among singletons, all twins and unlike-sex twins conceived with IUI or IVFT with that in a matched and random sample of infants conceived naturally. Finally, we compared the risks of major birth defects among IUI infants with that among IVFT infants.
Materials and Methods

Study population
All deliveries, births whether live or not and terminations of pregnancies which occurred in Burgundy from 1 January 2000 through 30 June 2009 were included in our study if the gestational age was at least 22 weeks and/or if the birthweight was .500 g. The infants conceived through IVF, ICSI and FET were merged in one group, defined as the IVFT group, as one of the goals of the study was to evaluate whether performing IUI represents a risk compared with IVF technologies (IVF, ICSI and FET). For singletons, within the IVFT group, IVF, ICSI and FET represent 16.2, 61.8 and 22% of conceptions, respectively, while for twins these percentages are 18.2, 60.8 and 21%, respectively. The study consisted of determining the risk of major birth defects in infants conceived with the use of ART as compared with infants conceived naturally, thanks to the cross analysis of two prospective databases, the BPN database and the database of the ART centres of Burgundy.
Data collection and anonymization procedure
The BPN database covers the 18 public and private hospitals of a French region with 1 640 000 inhabitants and 18 000 births annually. Since 2000, all deliveries and terminations of pregnancies that occurred in Burgundy at or after 22 completed weeks of gestation and/or with a birthweight .500 g are systematically recorded in an anonymous database used in order to regularly assess the BPN procedures (Cornet et al., 2001) . Maternal and neonatal medical data were obtained from the mandatory discharge abstracts for each hospitalized patient, comprising 20 specific indicators (11 for each mother and 9 for each newborn) (Sagot et al., 2003; Quantin et al., 2009) . During the time period of the study, Burgundy was the only region of France to record in its discharge database, the date of delivery and gestational age at delivery. Each hospital and ART center provides its own data on a voluntary basis.
The Burgundy ART databases include all IUI, IVF, ICSI and FET treatments resulting in deliveries or terminations of pregnancies as defined above.
Data were rendered anonymous in each hospital and each ART center using ANONYMAT software as previously described (Quantin et al., 1998a, b) before being sent to the committee in charge of the assessment of the perinatal network's performance (regional audit committee) (Sagot et al., 2003; Quantin et al., 2009) .
The two sets of databases were rendered anonymous before the probabilistic linkage was performed. The following patient's identifiers were anonymyzed: the woman's maiden name, first name, date of birth, zip code and theoretical date of delivery. Theses variables were utilized to calculate a probabilistic linkage based on a normal mixture model (Quantin et al., 1998a, b) .
Data validation and file linkage
The ANONYMAT software allows one to assign for each delivery (.22 weeks of gestation):
(i) women with their newborn (s), therefore to connect all over Burgundy all hospital stays in relation with women and their newborn (s); (ii) women with the type of conception of their newborn (s) (conceived with infertility treatment or not).
Analysis protocol
The BPN database included all the deliveries (≥22 weeks of gestation) from the 18 public and private hospitals of Burgundy. Within the BPN database, the information regarding an infertility treatment was reported, however the type of infertility treatment used was not specified (IUI, ICSI, IVF, FET, OI alone).
The ART database included all the women who have undergone ART in Burgundy with the type of ART specified (IUI, ICSI, IVF, FET).
The cross linkage between the two databases (BPN and ART) allowed us to isolate and to exclude from the study (i) a population of women who have undergone ART treatment (IUI, ICSI, IVF, FET) outside Burgundy; (ii) a population of women who have undergone OI alone either inside or outside Burgundy.
The women who have OI alone could not be differentiated; therefore, we were unable to study them specifically.
Infants born through ART (IUI and IVFT: 'exposed' groups) were exactly matched with infants conceived naturally ('unexposed' group) on plurality, maternal age at time of conception and year of conception. Then, a draw selected three 'unexposed' infants for one 'exposed' infant. Children conceived naturally are referred to as 'unexposed' in the article. We defined six 'exposed' groups: IVFT singletons (Group A), IUI singletons (Group B), IVFT all twins (Group C), IUI all twins (Group D), IVFT unlike-sex twins (Group E) and IUI unlike-sex twins (Group F). Triplets and higher order births were not considered owing to small numbers in the general population. Congenital birth defects were diagnosed at the time of hospital discharge whatever the infant stay considered; maternity unit and/or neonatal unit (infant mean age: 4 days for singletons and 8 days for twins). Major birth defects were defined according to the EUROCAT classification for subgroups of major congenital anomalies (Chapters 3.2 and 3.3). Minor anomalies were excluded in accordance with guidelines from EUROCAT.
Statistics
The three groups (unexposed, IUI, IVFT) were compared using, for quantitative characteristics, one-way analysis of variance or, if normality assumption was violated, the Kruskall -Wallis test. x 2 test or, in the case of very rare conditions, Fisher's exact test were used to compare the distributions of categorical variables across the three groups.
We estimated the strength of the association between infertility treatment (IUI or IVFT), compared with unexposed children, and the respective outcome, using exact conditional logistic regressions, which were adjusted for pre-existing and gestational diabetes. First order interactions between infertility treatment and the covariates were tested by a twotailed Wald test, and excluded from the model if they did not reach statistical significance at the 0.05 level. Crude odds ratios (OR) and adjusted OR (AOR) and their 95% confidence intervals (CI) were estimated.
Statistical analyses were performed using SAS 9.2 (SAS Institute Inc.). All hypotheses were tested at the two-tailed 0.05 significance level.
Results
A total of 7600 infants were analysed who correspond to 5700 unexposed infants and 1900 ART conceived infants. The distribution among each category (singletons and twins) was the following: All OR discussed in our study were adjusted for pre-existing and gestational diabetes (AOR). The distribution of diabetes cases among each category was the following: (i) Women who had given birth to singletons: unexposed (n ¼ 210, 5.2%); IVFT (n ¼ 79, 8.8%) and IUI (n ¼ 36, 8.1%). (ii) Women who had given birth to twins: unexposed (n ¼ 35, 2.1%); IVFT (n ¼ 11, 3.0%) and IUI (n ¼ 8, 4.2%).
Major congenital abnormalities according to the EUROCAT classification (Chapters 3.2 and 3.3)
Singletons
Singletons born after IUI and IVFT had an increased prevalence of major congenital malformations versus unexposed singletons (IUI: AOR 2.0, 95% CI 1.0-3.8; IVFT: AOR 2.0, 95% CI 1.3 -3.1) ( Table I) . After stratifying by organ system, the circulatory system malformations were found significantly increased in the IUI group (AOR 3.1; 95% CI 1.1 -8.6), Table I . The details of the nature of the defects indicated that these abnormalities referred mainly to septal heart defects (Supplementary data, Table SI ).
The prevalence of musculoskeletal abnormalities was significantly increased in both groups-IUI and IVFT (IUI: AOR 2.6; 95% CI 1.0-5.9; IVFT: AOR 1.9; 95% CI 1.0-3.8). In the IUI group, anomalies of the toes (hallux varus), spine (Klippel -Feil syndrome) and face (facial asymmetry) were observed while in the IVFT group we found defects associated with upper limb (shortening), hand (polysyndactyly, polydactyly), foot (talipes equinovarus, calcaneovarus) and congenital malformations of the diaphragm (hernia). Hip abnormalities were observed in both IUI and IVFT groups (Supplementary data, Table SI ).
All twins
Compared with unexposed twins, all twins born after IVFT but not IUI are at high risk for major congenital anomalies (AOR 3.0; 95% CI 1.6 -5.6). The analysis by organ system indicated that IVFT was associated with an increased prevalence of circulatory system anomalies (AOR 4.0; 95% CI 1.5-10.6) genital organ malformations (AOR 4.7; 95% CI 1.4 -15.9) and musculoskeletal anomalies (AOR 2.9; 95% CI 1.0-8.4) ( Table II) . Circulatory system anomalies were mainly associated with cardiac septal closure defects. Genital anomalies were predominantly hypospadias, ovarian cyst and malformations of the penis. Musculoskeletal anomalies included various types of defects (Supplementary data, Table SII ).
Unlike-sex twins
Unlike-sex twins born after IVFT but not IUI show a significantly higher risk for major birth defects compared with unlike-sex twins unexposed group (AOR 3.7; 95% CI 1.1-16.9). The analysis by organ system indicated that the circulatory system abnormalities were significantly increased (AOR 6.1; 95% CI 1.3 -38.5), Table III . Circulatory system anomalies were the same as described for all twins (Supplementary data, Table SIII) .
Comparison between IUI and IVFT
When comparing IUI with IVFT for major birth defects (Tables I -III) , no differences were observed for singletons (AOR 1.0; 95% CI 0.4-2.2), all twins (AOR 0.4; 95% CI 0.1-1.2) and unlike-sex twins (classification: AOR 0.3; 95% CI 0.1-4.5).
Discussion
Beyond the corroboration of excess risk of major birth defects in singletons born after IVFT (Rimm et al., 2004; Hansen et al., 2005; Wennerholm et al., 2009) , our study demonstrates a significant increase of major birth defects risks in singletons born after IUI. In our study, the prevalences of major congenital anomalies we found in our unexposed populations (singletons: 2.1%; twins: 2.4%) are in agreement with the prevalence of major congenital anomalies recorded in Europe (2.4%) and reported by Dolk et al. (2010) .
To achieve such results, we performed a retrospective cohort study which used the same source of data and the same classification of birth defects for all groups.
Furthermore, our results were obtained from a large validated population database (date of delivery and gestational age at delivery known) whose completeness and quality are regularly assessed (Cornet et al., 2001) . The study we performed consisted of matching exactly on plurality, maternal age at time of conception and year of conception, infants born through ART with infants conceived naturally. The ORs were adjusted on pre-existing and gestational diabetes for three reasons (i) we found that the number of patients suffering from diabetes in the ART group (IUI and IVFT) was significantly higher than in the unexposed group; (ii) it is well known that type I and type II diabetes are associated with increased teratogenesis (Sharp et al., 2005) . iii) type II diabetes that is diagnosed during Children with one or more malformations counted once for all major birth defects (all) but counted for each malformation in relevant subgroup (system). Infants with multiple birth defects could be included in several categories.
pregnancy, accounts for a significant proportion of gestational diabetes with a prevalence that dramatically increases over time. Other confounders could have been taken into consideration, such as occupational status, BMI, alcohol and coffee consumption. In our centre, all the women who benefitted from an ART underwent a medical screening which included the evaluation of exposure to toxins such as nicotine and alcohol. The women were included in our programme only after cessation of smoking and alcohol. Only a non-significant proportion of women did not quit. The information regarding occupational status, BMI and coffee consumption was unavailable to us. The two main potential weaknesses of our study are:
(i) The risk of differential diagnostic vigilance given that infants born after ART may be examined more carefully than children conceived naturally. If so, major birth defects should be diagnosed earlier. However, regarding major birth defects in infants born after IVF and ICSI, Hansen et al. (2002) have shown that the exclusion of defects detected with closer surveillance did not affect the evaluation of the risks and that two-thirds of major defects were diagnosed during the first week of life. Furthermore, because infants born after IUI are not considered at higher risk than children conceived naturally, physicians do not have any reason to examine these infants more closely. (ii) The fact that the data regarding medical terminations of pregnancies before 22 weeks of gestation were not recorded in the BPN database. Nevertheless, in France, the prenatal diagnosis offered to pregnant women (whether exposed to ART or not) is the same.
In France, all pregnant women can benefit from three ultrasound examinations, at 11 -14 weeks of gestation; 21 -24 weeks of gestation and 32-34 weeks of gestation (and more than three examinations in case of pathological obstetric conditions). A large national study revealed that 99.9% of pregnant women in France had at least one ultrasound examination during pregnancy and 97.4% had three or more; 80% of women ,38 years underwent a triple test screen and 76% had a nuchal translucency screen. The practices related to pregnancy termination following prenatal diagnosis did not differ according to whether ART was used (Enquêtes nationales périnatales : 1998, 2003) . In addition, both ART and prenatal diagnosis are offered free of charge in France.
Unlike most studies (Rimm et al., 2004; McDonald et al., 2005) , in our study we observed an increased risk of major birth defects in twins and unlike-sex twins conceived after IVFT. For instance, in the study of Zhu et al. (2006) no significant difference existed in the prevalence of congenital malformations among twins born after IVFT and IUI. Two hypotheses can be envisaged in order to explain the failure in demonstrating a higher prevalence of congenital anomalies in twins:
(i) the fact that there was no increase in prevalence between twins born after IUI and IVFT and twins from the general population. (ii) the fact that the authors did not take zygosity into account.
Birth defect rates in monozygotic twins are two times higher than in dizygotic twins (Hall, 2003; Glinianaia et al., 2008) . In the general population, monozygosity accounts for 0.4% (25% of twins) (The Eshre Capri Workshop Group, 2000; Vitthala et al., 2009 ) and dizygosity for 1.2% (75% of twins) of conceptions (The Eshre Capri Workshop Group, 2000) whereas in ART monozygosity accounts for 0.9% (Glinianaia et al., 2008) . In ART population, 95% of twins were dizygotic and 5% monozygotic. When the chorionicity data are not known, the analysis of unlike-sex twins containing only dizygotic chorionic twins allows us to consider the zygosity issue.
In our study, even if we considered the zygosity, we failed to demonstrate a significant increase in major birth defects in the IUI twins (all and unlike-sex twins). Regarding the significant increase, we reported in singletons (AOR 2.0; 95% CI 1.0-3.8) and not in twins (all twins: AOR 1.1; 95% CI 0.3-3.5; unlike-sex twins: AOR 1.3; 95% CI 0.1 -18.2), the outcome may not necessarily be different but may be simply related, most probably, to a small number of twins available for study (wide CI).
Singletons born after IUI were twice as likely as singletons from the general population to have major birth defects (AOR 2.0; 95%CI 1.0 -3.8). The details of the nature of the defects indicated that ART did not have a targeted effect on a specific anomaly. The most common anomalies observed in the unexposed group were also the most common in the ART group (IVFT and IUI groups). The circulatory, musculoskeletal and genital systems were the most affected, as is the case in the general population. We did not find any difference between infants conceived after IUI and infants conceived after IVFT.
The increased risk of congenital malformations could be partly related to ART but also to the underlying infertility status. The results by Zhu et al. (2006) suggest that the infertility characteristics could be responsible for the increased risk. Our results constitute the best evidence so far that the in vitro procedures per se (i.e. oocyte retrieval, sperm preparation, injection or insemination of the oocytes, embryo(s) culture) may not be the factors responsible for the excess risk of major birth defects in infants conceived with ART. In our study, we cannot rule out the involvement of OI in the risk of major birth defects, as OI is part of the IUI and IVF procedures.
However, it could be that the infertility status is the origin of the increased risk, as suggested by the study undertaken by Zhu et al. (2006) which revealed that subfertile couples with a time to pregnancy of more than 12 months who conceived without the need of any infertility treatment, give birth to singletons with an increased prevalence of congenital malformations.
On the basis of our results, it is necessary to design more studies (i) with a large number of infants studied in order to consider twins and unlike-sex twins; (ii) comparing subfertile couples conceiving without the need of any infertility treatment (time to pregnancy of .12 months) in order to state if ART itself increases the risks of major malformations. Finally, the potential risk associated with IUI should not be ignored, and information should be given not only to physicians performing the IUI but also to couples treated with IUI.
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Supplementary data are available at http://humrep.oxfordjournals.org/.
